𝔖 Bobbio Scriptorium

✦ LIBER ✦

31 Peginterferon α-2a (40 kDa) (PEGASYS®) versus peginterferon α-2a plus lamivudine versus lamivudine in HBeAg-positive chronic HBV: Effect of previous treatment and drug exposure on sustained response

Book ID: 117373543
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 105 KB
Volume: 42
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)81443-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

523 Effect of ALT flares on efficacy and

523 Effect of ALT flares on efficacy and safety of peginterferon α-2a (40 kDa) (PEGASYS®), peginterferon α-2a plus lamivudine and lamivudine in HBeAg-positive chronic hepatitis B (CHB)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 253 KB

484 On-treatment predictors of sustained

484 On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon α-2a (40 kDa) (PEGASYS®)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

71 Effect of genotype and other baseline

71 Effect of genotype and other baseline factors on response to peginterferon α-2a (40 kDa) (PEGASYS®) in HBeAg-positive chronic hepatitis B: Results from a large, randomised study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 239 KB